πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9745266

Indoline alkaloid compounds

The Regents of the University of Colorado Β· Granted Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701792

Composite compositions and methods of preparing and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701713

Compositions and methods for introduction of macromolecules into cells

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700628

Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding ther

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700492

Dental composites systems and methods of making the same and using same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9695229

Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9687527

Stable glucagon formulations for the treatment of hypoglycemia

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683025

Methods and compositions for treating cancer and inflammatory diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9675678

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9662307

Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use t

The Regents of the University of Colorado Β· Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650447

Complement receptor 2 (CR2) targeting groups

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9639665

Methods for diagnosis and intervention of hepatic disorders

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9631188

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9631092

Degradable thiol-ene polymers

The Regents of the University of Colorado Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9629848

Compounds that modulate autoimmunity and methods of using the same

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9603829

HSP90 inhibitors with modified toxicity

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562088

Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562015

Methods and compositions for enhanced drug delivery to the eye and extended delivery formu

The Regents of the University of Colorado, a body Β· Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9539231

Method for treating triple-negative breast cancer using AMPI-109

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9526760

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9522179

Compositions and methods for modulating cardiac conditions

The Regents of the University of Colorado Β· Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9518090

Compositions and methods for treating hepatitis B

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9517229

Treatment of breast cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9512481

Polymorphisms in the PDE3A gene

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted